Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Acq. announced
Inv. presentation
Quarterly results
Appointed director
CC transcript
Auditor change
Director departure

JUNIPER PHARMACEUTICALS INC (JNP) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/24/2011 BW Columbia Laboratories Added to Russell 3000 Index
05/16/2011 BW Columbia Laboratories Added to NASDAQ Biotechnology Index
05/10/2011 BW Columbia Laboratories Appoints Kip Martin as Vice President, Business Development
05/05/2011 BW Columbia Laboratories Reports First Quarter 2011 Financial Results
04/28/2011 BW Columbia Laboratories to Discuss First Quarter 2011 Financial Results on May 5, 2011, Conference Call
04/20/2011 BW Actient Pharmaceuticals LLC Acquires U.S. Rights to STRIANT from Columbia Laboratories
03/30/2011 BW Columbia Laboratories' Provides Update on PREGNANT Study Publication
03/10/2011 BW Columbia Laboratories Reports Fourth Quarter and Year End 2010 Financial Results
11/04/2010 BW Columbia Laboratories Reports Third Quarter 2010 Financial Results
10/21/2010 BW Columbia Laboratories to Discuss Third Quarter 2010 Financial Results on November 4 Conference Call
10/18/2010 BW Columbia Laboratories to Present at the NewsMakers in the Biotech Industry Conference on October 22, 2010
08/10/2010 BW Columbia Laboratories Repurchases 3.3 Million Shares of Common Stock
07/12/2010 BW Watson Designee Fred Wilkinson Appointed to Columbia Laboratories' Board to Directors
07/06/2010 BW Columbia Laboratories Completes Sale of Progesterone Assets to Watson Pharmaceuticals
07/01/2010 BW Columbia Laboratories Stockholders Approve Sale of Progesterone Assets to Watson Pharmaceuticals
05/18/2010 BW Columbia Laboratories Renews Agreement with Merck Serono for CRINONE in Foreign Markets
05/06/2010 BW Columbia Laboratories Reports First Quarter 2010 Financial Results
04/23/2010 BW Columbia Laboratories to Discuss First Quarter 2010 Financial Results on May 6, 2010, Conference Call
04/22/2010 BW CORRECTING and REPLACING Columbia Laboratories Announces Preliminary Results for the First Quarter of 2010
03/11/2010 BW CORRECTING and REPLACING Columbia Laboratories Reports Fourth Quarter and Year End 2009 Financial Results
03/05/2010 BW Columbia Laboratories Will Discuss Fourth Quarter and Year-End 2009 Financial Results on March 11, 2010 Conference Call
03/03/2010 BW Columbia Laboratories to Present at the Cowen and Company Health Care Conference on March 11, 2010

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy